Last reviewed · How we verify
NCT03914599
Protective Genetic Factors Against Neurological Diseases
trial in Neurological Disorder in 124 participants. Completed in 11 July 2022.
11 July 2022
Quick facts
| Lead sponsor | Wayne State University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 124 |
| Start date | 15 April 2019 |
| Primary completion | 11 July 2022 |
| Estimated completion | 11 July 2022 |
| Sites | 1 location across United States |
Conditions studied
- Neurological Disorder — all drugs for Neurological Disorder →
- Healthy Control — all drugs for Healthy Control →
Sponsor
Wayne State University
Who can join
Adults 18 to 100, any sex, with Neurological Disorder or Healthy Control. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
NIH Precision Medicine Initiative, started in May 2018, will enroll one million people through an online portal. It hopes to identify genetic variants affecting a variety of human phenotypic outcomes. A giant set of data like this may enable an association of genetic variants with a certain phenotype. However, the association is often compromised due to the collection of phenotypic data that is not well controlled or standardized creating "noisy" data. These phenotypic "noises" can be largely eliminated in clinical studies with stringent criteria and standardization of outcome measurements. In this study, by looking mainly at genetic information and nerve conduction speed, we hope to eliminate the extra "noises" in the data set. Eliminating the extra "noises" should allow us to be able to determine if there are genetic differences between neurological disorders and healthy controls, and if these genetic differences can be attributed to the speed of the nerve conduction.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03914599
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Neurological Disorder
Currently open trials in the same condition.
- NCT07456475 — Metaverse Applications in Clinical Neurorehabiliation: Device Feasibility · NA · active not recruiting
- NCT05106725 — Wearable Devices and Biomarkers Project (Healthiomics) · recruiting
- NCT06278961 — Families Filming Infants Learning Movement · recruiting
- NCT04436068 — Hyperfine Portable MRI in Hydrocephalus and Other Conditions Prompting Outpatient Brain Imaging · NA · active not recruiting
- NCT04368481 — MIDI (MR Imaging Abnormality Deep Learning Identification) · recruiting
Other Wayne State University trials
Trials by the same sponsor.
- NCT07219394 — Peer-Delivered Behavioral Activation in a CCBHC · NA · recruiting
- NCT07123467 — Cannabidiol-Assisted Learning for Managing Generalized Anxiety Disorder · Phase 3 · recruiting
- NCT07222306 — Cannabis, Neuroinflammation, and Suicidal Ideation: A Supplemental Brain Imaging Study · enrolling by invitation
- NCT05684978 — Efficacy and Safety of Perampanel in the Treatment of Refractory Status Epilepticus · Phase 4 · terminated
- NCT06381180 — Warrior CARE: Cannabis Behavioral Health · Phase 1, PHASE2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03914599 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Wayne State University
- Last refreshed: 18 July 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03914599.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing